Want to see AU:IXC full AI Analyst Report?
Invex Therapeutics Ltd. (IXC) Income Statement
Invex Therapeutics Ltd. Income Statement
Last quarter (Q4 2026), Invex Therapeutics Ltd.'s total revenue was $0.00, a decrease of 100.00% from the same quarter last year. In Q4, Invex Therapeutics Ltd.'s net income was $-636.77K. See Invex Therapeutics Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| $ 0.00 | $ 229.08K | $ 1.21M | $ 459.08K | $ 182.25K | |
| $ 0.00 | $ 229.08K | $ 1.21M | $ 459.08K | $ 182.25K | |
| $ 1.54M | $ 938.39K | $ 3.35M | $ 8.98M | $ 4.22M | |
| Depreciation and Amortization | $ 0.00 | $ 709.30K | $ 2.13M | $ 8.55M | $ 0.00 |
| $ -1.54M | $ 0.00 | $ -720.37K | $ 337.94K | $ -4.14M | |
| $ -1.54M | $ -709.30K | $ -2.13M | $ -8.55M | $ -4.03M | |
| $ 145.25K | $ 232.44K | $ 491.82K | $ 797.08K | $ 79.88K | |
| $ -1.40M | $ -476.87K | $ -2.85M | $ -7.75M | $ -3.95M | |
| $ -1.35M | $ -476.87K | $ -1.64M | $ -7.75M | $ -3.95M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.02 | $ -0.01 | $ -0.02 | $ -0.10 | $ -0.05 |
| Diluted EPS | $ -0.02 | $ -0.01 | $ -0.02 | $ -0.10 | $ -0.05 |
| Weighted Average Shares Outstanding | 75.15M | 75.69M | 75.31M | 75.15M | 75.15M |
| Weighted Average Shares Outstanding (Diluted) | 75.15M | 75.69M | 75.31M | 75.15M | 75.15M |
Currency in AUD
